You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT ARCHIVES
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 99 No. 1, JANUARY 1957 TABLE OF CONTENTS
  Archives
  •  Online Features
  ARTICLES
 This Article
 •References
 •Full text PDF
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citing articles on Web of Science (13)
 •Contact me when this article is cited
 Related Content
 •Similar articles in this journal
 Social Bookmarking
  Add to CiteULike Add to Connotea Add to Del.icio.us Add to Digg Add to Reddit Add to Technorati Add to Twitter What's this?

Renal Excretion of Phosphorus in Pseudohypoparathyroidism

Observations on the Effects of Probenecid and Acetazoleamide in Two Patients

ROBERT B. BAER, M.D.; THOMAS BENEDEK, M.D.; IRAM. ROSENTHAL; HYMAN J. ZIMMERMAN, M.D.

AMA Arch Intern Med. 1957;99(1):14-21.

Since this article does not have an abstract, we have provided the first 150 words of the full text PDF and any section headings.

Pseudohypoparathyroidism, a disease first described by Albright and co-workers,1 differs from true hypoparathyroidism in pathogenesis despite the biochemical and clinical similarities of the two conditions.1-6 High serum phosphorus levels and low serum calcium levels are characteristic of both conditions. Hypocalcemic tetany, intracranial calcification, and cataracts may be found in both diseases (Table). While true hypoparathyroidism results from a deficiency in circulating parathyroid hormone, pseudohypoparathyroidism seems to be the result of inadequate end-organ response to parathyroid secretion.1 Differences in response to injected parathyroid extract have been used for the differential diagnosis of the two diseases.1,2 Despite the underlying difference in pathophysiology, the treatment of pseudohypoparathyroidism, like that of true hypoparathyroidism, has been based on the administration of either dihydrotachysterol or vitamin D and a low-phosphorus diet.1-3 In general, the response of patients with true hypoparathyroidism has been more satisfactory.3

Probenecid (Benemid) has been reported to have an effect on phosphorus metabolism . . . [Full Text PDF of this Article]


Author Affiliations

Chicago

Medical Service, West Side Veterans Administration Hospital, and Departments of Medicine and Pediatrics, University of Illinois College of Medicine. Formerly Resident in Medicine, West Side Veterans Administration Hospital (Dr. Baer); formerly Resident in Medicine, Research and Educational Hospitals, University of Illinois (Dr. Benedek); Associate Professor of Pediatrics, University of Illinois College of Medicine (Dr. Rosenthal), and Chief Medical Service, West Side Veterans Administration Hospital, and Clinical Associate Professor of Medicine, University of Illinois College of Medicine (Dr. Zimmerman).


Footnotes

Submitted for publication May 16, 1956.



Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter     What's this?





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 1957 American Medical Association. All Rights Reserved.